Phthalate-induced testicular dysgenesis syndrome: Leydig cell influence

Trends in Endocrinology and Metabolism

Volumn 20, Issue 3, 2009, Pages 139-145

  Hu, Guo Xin ^a   Lian, Qing Quan ^a   Ge, Ren Shan ^a,b   Hardy, Dianne O ^b   Li, Xiao Kun ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCRINE DISRUPTOR; PHTHALIC ACID; PHTHALIC ACID BENZYL BUTYL ESTER; PHTHALIC ACID DIBUTYL ESTER; PHTHALIC ACID DIETHYL ESTER; PHTHALIC ACID DIOCTYL ESTER; POLYVINYLCHLORIDE;

CELL FUNCTION; CRYPTORCHISM; DEL CASTILLO SYNDROME; ENVIRONMENTAL EXPOSURE; GONADAL DYSGENESIS; HUMAN; HYPOSPADIAS; LEYDIG CELL; MALE INFERTILITY; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; TESTIS CANCER;

ANIMALS; CRYPTORCHIDISM; HUMANS; HYPOSPADIAS; LEYDIG CELLS; MALE; PHTHALIC ACIDS; TESTICULAR DISEASES; TESTICULAR NEOPLASMS; TESTIS;

EID: 62649088559     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2008.12.001     Document Type: Review

References (66)

1. Skakkebaek N.E., et al. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 16 (2001) 972-978
2. Rajpert-De Meyts E. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum. Reprod. Update 12 (2006) 303-323
3. Ge R.-S., and Hardy M.P. Regulation of Leydig cells during pubertal development. In: Payne A.H., and Hardy M.P. (Eds). The Leydig Cell in Health and Disease (2007), Humana Press 55-70
4. Carlsen E., et al. Evidence for decreasing quality of semen during past 50 years. BMJ 305 (1992) 609-613
5. Main K.M., et al. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ. Health Perspect. 114 (2006) 270-276
6. Goldman J.M., et al. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid activity in the female rat. A focus on the EDSTAC recommendations. Crit. Rev. Toxicol. 30 (2000) 135-196
7. Ge R.S., et al. Phthalate ester toxicity in Leydig cells: developmental timing and dosage considerations. Reprod. Toxicol. 23 (2007) 366-373
8. Sharpe R.M., and Skakkebaek N.E. Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil. Steril. 89 (2008) e33-e38
9. Swan S.H., et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ. Health Perspect. 113 (2005) 1056-1061
10. Foster P.M., et al. Changes in ultrastructure and cytochemical localization of zinc in rat testis following the administration of di-n-pentyl phthalate. Toxicol. Appl. Pharmacol. 63 (1982) 120-132
11. O'Shaughnessy P.J., et al. The foetal Leydig cell - differentiation, function and regulation. Int. J. Androl. 29 (2006) 90-95
12. Emmen J.M., et al. Involvement of insulin-like factor 3 (Insl3) in diethylstilbestrol-induced cryptorchidism. Endocrinology 141 (2000) 846-849
13. Scott D.J., et al. Characterization of the rat INSL3 receptor. Ann. N. Y. Acad. Sci. 1041 (2005) 13-16
14. Zimmermann S., et al. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol. Endocrinol. 13 (1999) 681-691
15. Benton L., et al. Differentiation of adult Leydig cells. J. Steroid Biochem. Mol. Biol. 53 (1995) 61-68
16. Prince F.P. The triphasic nature of Leydig cell development in humans, and comments on nomenclature. J. Endocrinol. 168 (2001) 213-216
17. Ge R.S., and Hardy M.P. Variation in the end products of androgen biosynthesis and metabolism during postnatal differentiation of rat Leydig cells. Endocrinology 139 (1998) 3787-3795
18. de Santa Barbara P., et al. Expression and subcellular localization of SF-1, SOX9, WT1, and AMH proteins during early human testicular development. Dev. Dyn. 217 (2000) 293-298
19. Hardy M.P., et al. Kinetic studies on the development of the adult population of Leydig cells in testes of the pubertal rat. Endocrinology 124 (1989) 762-770
20. Hakola K., et al. Dose and time relationships of intravenously injected rat recombinant luteinizing hormone and testicular testosterone secretion in the male rat. Biol. Reprod. 59 (1998) 338-343
21. Dufau M.L. The luteinizing hormone receptor. Annu. Rev. Physiol. 60 (1998) 461-496
22. Manova K., et al. Gonadal expression of c-kit encoded at the W locus of the mouse. Development 110 (1990) 1057-1069
23. Baker P.J., et al. Differentiation of adult-type Leydig cells occurs in gonadotrophin-deficient mice. Reprod. Biol. Endo. (2003). www.rbej.com 10.1186/1477-7827-1-4
24. Zhang F.P., et al. Molecular characterization of postnatal development of testicular steroidogenesis in luteinizing hormone receptor knockout mice. Endocrinology 145 (2004) 1453-1463
25. Lo K.C., et al. De novo testosterone production in luteinizing hormone receptor knockout mice after transplantation of leydig stem cells. Endocrinology 145 (2004) 4011-4015
26. Davidoff M.S., et al. Progenitor cells of the testosterone-producing Leydig cells revealed. J. Cell Biol. 167 (2004) 935-944
27. Ge R.S., et al. In search of rat stem Leydig cells: identification, isolation, and lineage-specific development. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2719-2724
28. Harris C.A., et al. The estrogenic activity of phthalate esters in vitro. Environ. Health Perspect. 105 (1997) 802-811
29. Parks L.G., et al. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol. Sci. 58 (2000) 339-349
30. Lin H., et al. Involvement of testicular growth factors in fetal Leydig cell aggregation after exposure to phthalate in utero. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 7218-7222
31. Mahood I.K., et al. Abnormal Leydig Cell aggregation in the fetal testis of rats exposed to di (n-butyl) phthalate and its possible role in testicular dysgenesis. Endocrinology 146 (2005) 613-623
32. Mahood I.K., et al. Cellular origins of testicular dysgenesis in rats exposed in utero to di(n-butyl) phthalate. Int. J. Androl. 29 (2006) 148-154
33. Gazouli M., et al. Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor alpha. Endocrinology 143 (2002) 2571-2583
34. Lemberger T., et al. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell Dev. Biol. 12 (1996) 335-363
35. Schultz R., et al. Expression of peroxisome proliferator-activated receptor alpha messenger ribonucleic acid and protein in human and rat testis. Endocrinology 140 (1999) 2968-2975
36. Corton J.C., and Lapinskas P.J. Peroxisome proliferator-activated receptors: mediators of phthalate ester-induced effects in the male reproductive tract?. Toxicol. Sci. 83 (2005) 4-17
37. Hurst C.H., and Waxman D.J. Activation of PPARα and PPARγ by environmental phthalate monoesters. Toxicol. Sci. 74 (2003) 297-308
38. Lampen A., et al. Teratogenic phthalate esters and metabolites activate the nuclear receptors PPARs and induce differentiation of F9 cells. Toxicol. Appl. Pharmacol. 188 (2003) 14-23
39. Lovekamp-Swan T., et al. Dual activation of PPARα and PPARγ by mono-(2-ethylhexyl) phthalate in rat ovarian granulosa cells. Mol. Cell. Endocrinol. 201 (2003) 133-141
40. Ahamed S., et al. Signal transduction through the Ras/Erk pathway is essential for the mycoestrogen zearalenone-induced cell-cycle progression in MCF-7 cells. Mol. Carcinog. 30 (2001) 88-98
41. Foster P.M., et al. Effects of phthalate esters on the developing reproductive tract of male rats. Hum. Reprod. Update 7 (2001) 231-235
42. Ema M., et al. Critical period for adverse effects on development of reproductive system in male offspring of rats given di-n-butyl phthalate during late pregnancy. Toxicol. Lett. 111 (2000) 271-278
43. Zhang Y.H., et al. Phthalate exposure and human semen quality in Shanghai: a cross-sectional study. Biomed. Environ. Sci. 19 (2006) 205-209
44. Marsee K., et al. Estimated daily phthalate exposures in a population of mothers of male infants exhibiting reduced anogenital distance. Environ. Health Perspect. 114 (2006) 805-809
45. Sharpe R.M. Hormones and testis development and the possible adverse effects of environmental chemicals. Toxicol. Lett. 120 (2001) 221-232
46. Fisher J.S., et al. Human 'testicular dysgenesis syndrome': a possible model using in-utero exposure of the rat to dibutyl phthalate. Hum. Reprod. 18 (2003) 1383-1394
47. Wilson V.S., et al. Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rat testis. Toxicol. Lett. 146 (2004) 207-215
48. Hutchison G.R., et al. The origins and time of appearance of focal testicular dysgenesis in an animal model of testicular dysgenesis syndrome: evidence for delayed testis development? Int. J. Androl. 31 (2007) 103-110
49. McKinnell C., et al. Expression of insulin-like factor 3 protein in the rat testis during fetal and postnatal development and in relation to cryptorchidism induced by in utero exposure to di (n-Butyl) phthalate. Endocrinology 146 (2005) 4536-4544
50. Mahood I.K., et al. In utero exposure to di(n-butyl) phthalate and testicular dysgenesis: comparison of fetal and adult end points and their dose sensitivity. Environ. Health Perspect. 115 Suppl 1 (2007) 55-61
51. Shono T., and Suita S. Reasonable explanation for both the antiandrogenic mechanism of DBP and DBP-induced Leydig cell hyperplasia in prenatally DBP-treated rats. Toxicol. Appl. Pharmacol. 164 (2000) 336
52. Mylchreest E., et al. Fetal testosterone insufficiency and abnormal proliferation of Leydig cells and gonocytes in rats exposed to di(n-butyl) phthalate. Reprod. Toxicol. 16 (2002) 19-28
53. Scott H.M., et al. Role of androgens in fetal testis development and dysgenesis. Endocrinology 148 (2007) 2027-2036
54. Culty M., et al. In utero exposure to di-(2-ethylhexyl) phthalate exerts both short-term and long-lasting suppressive effects on testosterone production in the rat. Biol. Reprod. 78 (2008) 1018-1028
55. Barlow N.J., et al. Male reproductive tract lesions at 6, 12, and 18 months of age following in utero exposure to di(n-butyl) phthalate. Toxicol. Pathol. 32 (2004) 79-90
56. Akingbemi B.T., et al. Phthalate-induced Leydig cell hyperplasia is associated with multiple endocrine disturbances. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 775-780
57. Bosland M.C. Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. Prog. Clin. Biol. Res. 394 (1996) 309-352
58. Langley-Evans S.C. Intrauterine programming of hypertension by glucocorticoids. Life Sci. 60 (1997) 1213-1221
59. Seckl J.R., et al. Placental 11 beta-hydroxysteroid dehydrogenase and the programming of hypertension. J. Steroid Biochem. Mol. Biol. 55 (1995) 447-455
60. Dahlof L.G., et al. Influence of maternal stress on the development of the fetal genital system. Physiol. Behav. 20 (1978) 193-195
61. Ward I.L., and Reed J. Prenatal stress and prepuberal social rearing conditions interact to determine sexual behavior in male rats. Behav. Neurosci. 99 (1985) 301-309
62. Han, L. et al. (2009) In utero and lactational exposures to diethylhexyl-phthalate affect two populations of leydig cells in male Long-Evans rats. Biol. Reprod. DOI:10.1095/biolreprod.108.072975 (www.biolreprod.org)
63. Phillips D.M., et al. Corticosteroid 11β-dehydrogenase in rat testis. Endocrinology 125 (1989) 209-216
64. Alikhani-Koopaei R., et al. Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J. Clin. Invest. 114 (2004) 1146-1157
65. Crews D., and McLachlan J.A. Epigenetics, evolution, endocrine disruption, health, and disease. Endocrinology 147 (2006) S4-S10
66. Newbold R.R., et al. Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol. Carcinogenesis 21 (2000) 1355-1363